article

1. Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America..  AIDS (London, England).  38:1366-1374. 2024
2. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study..  PLoS medicine.  21:-. 2024
3. Hospital Readmissions Among Persons With Human Immunodeficiency Virus in the United States and Canada, 2005-2018: A Collaboration of Cohort Studies..  The Journal of infectious diseases.  228:1699-1708. 2023
4. Waitlist-controlled trial of an online intervention to address mental health among older people living with HIV..  Antiviral therapy.  28:-. 2023
5. Tideswell Emerging Leaders in Aging Special Interest Group: Cultivating a growing community of Geriatrics leaders..  Journal of the American Geriatrics Society.  72:961-964. 2023
6. Preventive and Sexual Health in LGBTQ+ Older Adults..  Clinics in geriatric medicine.  40:223-237. 2023
7. Qualitative Examination of the Impact of the COVID-19 Pandemic on Access and Adherence to Pre-exposure Prophylaxis (PrEP) Among Sexual and Gender Minorities..  AIDS education and prevention : official publication of the International Society for AIDS Education.  35:255-267. 2023
8. Engagement of Sexual Violence Survivors in Research: Trauma-Informed Research in the THRIVE Study..  Violence against women.  29:-. 2022
9. Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  75:297-304. 2022
10. Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March-December 2020..  Journal of acquired immune deficiency syndromes (1999).  90:369-376. 2022
11. Editorial: Chronic Pain and Health Disparities in Older Adults With Complex Needs..  Frontiers in pain research (Lausanne, Switzerland).  -. 2022
12. Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination..  The British journal of dermatology.  187:271-273. 2022
13. Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States..  AIDS (London, England).  36:1095-1103. 2022
14. Genital Inflammation Is Not Associated With Decreased Vaginal Tenofovir Concentrations in Women Taking Oral PrEP..  Journal of acquired immune deficiency syndromes (1999).  89:390-395. 2022
15. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study..  The lancet. HIV.  -. 2022
16. Racial and ethnic disparities in COVID-19 disease incidence independent of comorbidities, among people with HIV in the US..  medRxiv : the preprint server for health sciences.  2021
17. 'Ending the HIV epidemic': where are African American women in the plan?.  AIDS (London, England).  35:2541-2544. 2021
18. Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study..  Journal of the American Academy of Dermatology.  87:649-651. 2021
19. Pathogenesis of obstructive sleep apnea in people living with HIV..  Journal of applied physiology (Bethesda, Md. : 1985).  131:1671-1678. 2021
20. Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020..  medRxiv : the preprint server for health sciences.  2021
21. Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection..  Viruses.  13. 2021
22. Impact of switching to tenofovir alafenamide on weight gain as compared to maintaining a non-tenofovir alafenamide containing regimen..  Medicine.  100:-. 2021
23. Prevalence of and Factors Associated With Genital and Extragenital Chlamydia and Gonorrhea Among Transgender Women in HIV Care in the United States, 2005 to 2016..  Sexually transmitted diseases.  48:410-416. 2021
24. Bone Mineral Density Screening Among People With HIV: A Population-Based Analysis in the United States..  Open forum infectious diseases.  8:-. 2021
25. Telomere length is associated with HIV infection, methamphetamine use, inflammation, and comorbid disease risk..  Drug and alcohol dependence.  -. 2021
26. The biobehavioral impacts of sexual violence: Findings from an acute repeat survivor of vaginal rape..  Women's health (London, England).  -. 2021
27. The Role of Stress and Genital Immunity in Sexual Trauma and HIV Susceptibility Among Adolescent Girls and Adult Women (The THRIVE Study): Protocol for a Longitudinal Case-Control Study..  JMIR research protocols.  9:-. 2020
28. Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living With Human Immunodeficiency Virus in the United States (2005-2016)..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  71:2405-2413. 2020
29. An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics..  Emerging microbes & infections.  9:2333-2347. 2020
30. Glucan rich nutrition does not increase gut translocation of beta-glucan..  Mycoses.  64:24-29. 2020
31. Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options..  AIDS (London, England).  34:2051-2059. 2020
32. The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging..  AIDS research and human retroviruses.  36:973-981. 2020
33. Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States..  Open forum infectious diseases.  7:-. 2020
34. Association of Pain and Pain Medication Use with Multiple Characteristics of Older People Living with HIV..  AIDS research and human retroviruses.  36:663-669. 2020
35. What lessons it might teach us? Community engagement in HIV research..  Current opinion in HIV and AIDS.  15:142-149. 2020
36. Loneliness among older adults living with HIV: the "older old" may be less lonely than the "younger old"..  AIDS care.  33:375-382. 2020
37. Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Patients With HIV Infection..  Open forum infectious diseases.  7:-. 2020
38. Successful optimization of antiretroviral regimens in treatment-experienced people living with HIV undergoing liver transplantation..  Transplant infectious disease : an official journal of the Transplantation Society.  21:-. 2019
39. HEAL.  mBio.  10. 2019
40. Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging..  AIDS research and human retroviruses.  35:985-998. 2019
41. Encouraging Community Engagement in the Performance of Research at the Intersection of HIV and Aging..  AIDS research and human retroviruses.  35:979-981. 2019
42. HIV and Aging: Reconsidering the Approach to Management of Comorbidities..  Infectious disease clinics of North America.  33:769-786. 2019
43. Inflammatory flaccid myelitis in a patient with both anti-CRMP-5 IgG and CNS HIV escape..  BMJ case reports.  12. 2019
44. The As and Bs of HIV and Hepatitis Co-Infection..  Tropical medicine and infectious disease.  4. 2019
45. Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV..  Journal of acquired immune deficiency syndromes (1999).  79:399-406. 2018
46. Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date..  HIV/AIDS (Auckland, N.Z.).  203-213. 2018
47. Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594..  AIDS and behavior.  22:2698-2710. 2018
48. Current Treatment Options for HIV Elite Controllers: a Review..  Current treatment options in infectious diseases.  10:302-309. 2018
49. Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc..  Journal of virology.  92. 2018
50. Sexual Partner Concurrency Among Partners Reported by MSM with Recent HIV Infection..  AIDS and behavior.  21:3026-3034. 2017
51. Short Communication: Resolution of Tenofovir Disoproxil Fumarate Induced Fanconi Syndrome with Switch to Tenofovir Alafenamide Fumarate in a HIV-1 and Hepatitis B Coinfected Patient..  AIDS research and human retroviruses.  33:718-722. 2017
52. HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen..  HIV clinical trials.  18:67-74. 2017
53. Concurrency and HIV transmission network characteristics among MSM with recent HIV infection..  AIDS (London, England).  30:2875-2883. 2016
54. A randomized controlled clinical trial on the impact of CCR5 blockade with maraviroc in early infection on T-cell dynamics..  Medicine.  95:-. 2016
55. Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue..  Journal of acquired immune deficiency syndromes (1999).  72:e48-50. 2016
56. Antiretroviral therapy in the elite controller: justified or premature?.  The Journal of infectious diseases.  211:1689-91. 2014
57. Pre-Exposure Prophylaxis to Prevent HIV Infection: Why Do We Need It, What Are the Limitations, and Can We Successfully Provide It Today?.  LGBT health.  1:250-2. 2014
58. Reply to Sachdev et al..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  58:-. 2014
59. Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection..  AIDS (London, England).  28:841-9. 2014
60. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  58:704-12. 2013
61. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection..  AIDS (London, England).  27:1921-31. 2013
62. Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells..  Journal of molecular medicine (Berlin, Germany).  91:261-70. 2012
63. Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection..  Journal of clinical microbiology.  50:1874-8. 2012
64. Tissue-specific HIV-1 infection: why it matters..  Future virology.  6:869-882. 2011
65. Bartonella henselae infection of prosthetic aortic valve associated with colitis..  Vector borne and zoonotic diseases (Larchmont, N.Y.).  11:1503-5. 2011